Advanced Search
Contact | Corporate | Help

CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography

Sponsors:
  • Washington University School of Medicine
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
CAPTAIN
  • Age-Related Macular Degeneration
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Lucentis (ranibizumab)
Enrollment:
20

Additional information about NCT00500344.


SourceSolution © 2008-2012